TPE Benefits: How Therapeutic Plasma Exchange Supports Health and Longevity

A New Lens on Ageing and Disease

Scientific understanding of ageing and disease is increasingly focused on the role of the blood and the substances circulating within it. Over time, proteins linked to inflammation, metabolic waste products, and other circulating factors can build up and influence how cells function, how tissues repair, and how different systems in the body communicate. This internal environment is now recognised as an important contributor to a wide range of chronic conditions as well as the ageing process itself.

Therapeutic Plasma Exchange is a blood cleansing treatment that offers a way to work directly with this system. By removing and replacing a portion of the plasma, it can reduce levels of certain circulating factors and support a more balanced internal environment, depending on the clinical context.

At Reborne Longevity, we are one of a small number of private clinics offering Therapeutic Plasma Exchange in a fully equipped clinical setting. Treatment is delivered using advanced centrifugal technology that is also used across the NHS, under the supervision of an experienced clinical team.

What Is Therapeutic Plasma Exchange?

Therapeutic Plasma Exchange, or TPE, is a clinically established, doctor-led blood plasma exchange therapy that has long been used within hospital medicine. What is less common is access to this level of care outside of traditional hospital settings. At Reborne Longevity, TPE is delivered within a fully CQC regulated, hospital grade clinical environment in Marylebone, using centrifugal technology widely embedded across the NHS and supported by a well established safety profile.

At its core, TPE is designed to address changes in the composition of the bloodstream over time. As we age or develop chronic conditions, blood plasma can accumulate inflammatory molecules, immune byproducts, damaged proteins, and environmental toxins. These circulating factors do not simply signal disease. They can actively contribute to it by sustaining inflammation, disrupting cellular energy production, and accelerating biological ageing.

TPE intervenes directly in this process by filtering the blood and removing these harmful components. The procedure involves drawing a small volume of blood and passing it through a specialised medical filtration system. This separates the plasma, the liquid portion of the blood, from the red and white blood cells. The plasma, which contains the unwanted substances, is removed and replaced with a carefully selected fluid before the blood cells are returned to the body.

By removing entire groups of circulating molecules rather than targeting them individually, TPE offers a systemic approach to restoring internal balance. It can be understood as a controlled reset of the bloodstream, creating a cleaner biological environment in which the body can function, regulate, and repair more effectively.

Why Plasma Matters for Health and Ageing

Plasma is one of the body’s most important regulatory systems, responsible for transporting immune signals, proteins, lipids, hormones, and waste products throughout the body. In optimal health, this system maintains a delicate balance. However, with age and under certain physiological stresses, the composition of plasma begins to shift, with an increasing accumulation of inflammatory and immune-related molecules that can influence how the body functions over time.

This process is closely linked to what is known as immunosenescence, the gradual decline and restructuring of the immune system with age. A key feature of immunosenescence is a state of persistent low-grade inflammation, often referred to as inflammaging. Research published in Frontiers in Medicine demonstrates that specific circulating immune factors, including IL-6, sPD-1, and sCD28, increase with age and are strongly associated with this process. These molecules are involved in immune activation, inflammatory signalling, and T cell regulation, and their elevation reflects a shift toward chronic immune stimulation and reduced immune efficiency. The study also showed that the combined presence of these markers provides a more accurate indication of immune ageing than any single factor alone, highlighting how multiple pathways interact to drive systemic decline.

As these inflammatory and immune mediators accumulate in the bloodstream, they can sustain chronic inflammation, disrupt cellular communication, and impair the body’s ability to repair and regenerate. Over time, this contributes not only to accelerated biological ageing but also to increased susceptibility to a wide range of chronic conditions. Importantly, this process is not driven by a single molecule, but by a network of circulating factors that collectively shape the internal environment of the body.

Therapeutic Plasma Exchange works by directly intervening in this system. By removing plasma and replacing it with a clean solution, TPE reduces the burden of these circulating inflammatory and immune-associated molecules. In doing so, it offers a way to lower biological stress within the bloodstream and support a more balanced internal environment, which may be more conducive to healthy ageing and improved physiological resilience.

Clinical Pathways Where TPE May Be Applied

At Reborne Longevity, Therapeutic Plasma Exchange is used selectively across five core clinical pathways, each supported by a distinct and evolving evidence base.

BIOLOGICAL AGEING

In the context of biological ageing, emerging research suggests that modifying the composition of plasma may influence markers of biological age. A landmark placebo-controlled human trial published in Aging Cell by the Buck Institute in 2025 demonstrated that reducing pro-inflammatory and age-associated molecules may support a shift toward a more regenerative physiological state. While this field continues to develop, it reflects a broader movement toward treating ageing as a modifiable biological process.

Autoimmune & Inflammatory Conditions

Therapeutic plasma exchange for autoimmune disease and inflammatory conditions, is clinically well-established. These diseases are often driven by harmful immune proteins circulating in the bloodstream. By removing these directly, TPE can reduce immune system overactivity and inflammation, offering more rapid relief in selected cases where medication alone may be insufficient or slower to act.

COGNITIVE HEALTH

Cognitive health optimisation represents another area of growing interest. Research is increasingly exploring the relationship between systemic inflammation and brain function. In conditions such as Alzheimer’s disease, where amyloid proteins accumulate in the brain, reducing circulating levels in the blood may support the brain’s natural clearance processes. The AMBAR study demonstrated that plasma exchange may slow cognitive and functional decline in selected patients, although it is not considered a cure and is always approached within a broader clinical framework.

CARDIOVASCULAR RISK REDUCTION

For individuals with elevated lipoprotein(a) (Lp[a]), a genetically determined cardiovascular risk factor that is largely unresponsive to lifestyle changes and most medications, TPE may be considered in carefully selected cases. TPE works by removing and replacing a portion of the blood plasma, which can temporarily reduce circulating levels of Lp(a) along with other plasma-bound factors. While TPE is not a permanent solution and levels may rise again over time, this physical removal of Lp(a) may help reduce overall cardiovascular risk in certain high-risk individuals. As with all medical interventions, its use should be guided by clinical assessment and specialist care.

TOXIN & HEAVY METAL BURDEN

TPE may also be used in the context of toxin and heavy metal burden. As described by Global Apheresis Certain substances, including lead, mercury, and environmental toxins, bind tightly to plasma proteins, making them difficult to eliminate. By removing the plasma itself, TPE allows these bound toxins to be extracted directly, although this remains an evolving area guided by detailed diagnostic testing and clinical judgement.

What to Expect from Treatment

A typical TPE session lasts between 90 minutes and three hours and takes place in a calm, private clinical setting. During this time, you’ll be comfortably seated or reclined while your blood is gently circulated through a specialised filtration system. You’ll be looked after throughout by an experienced clinical team, who continuously monitor you to ensure everything runs smoothly. Most people describe the experience as similar to a long IV drip, with little to no discomfort. It’s normal to feel a bit tired afterwards, so we usually recommend taking it easy for the rest of the day. Before your session, you’ll receive clear guidance on how to prepare, and your aftercare will be tailored to you-so you always know exactly what to expect.

Therapeutic Plasma Exchange has a strong safety record when carried out in a regulated clinical environment. At Reborne, we use hospital-grade equipment that meets established medical standards and is widely used across global healthcare systems, including the NHS. As with any medical treatment, there are some potential risks-such as temporary changes in blood pressure, mild electrolyte shifts, or a very small risk of infection. These are carefully managed through continuous monitoring and strict clinical protocols. Every treatment plan is personalised and led by our clinical team, ensuring decisions are appropriate, evidence-informed, and aligned with your overall health.

Is TPE Right for You?

At our Mayfair medical clinic, every patient journey is guided by P4 medicine - an approach that is predictive, preventive, personalised, and participatory - beginning with a detailed understanding of your current health and shaped around your individual needs. 

Therapeutic Plasma Exchange is not a general wellness treatment or optimisation tool, but a consultant-led medical intervention delivered under strict clinical supervision. Every case begins with a comprehensive assessment, including a detailed review of medical history, current health status, and relevant diagnostics.

TPE is only considered where there is a clear clinical rationale. It is never offered in isolation, and all decisions are guided by defined clinical pathways and specialist oversight. Initial screening consultations are available and may be redeemable against treatment where appropriate. Following this evaluation, the clinical team determines whether TPE is suitable and which, if any, treatment pathway is indicated. No procedure is undertaken without informed consent and a personalised care plan aligned with the individual’s broader health profile.

BOOK A THERAPEUTIC PLASMA EXCHANGE CONSULT

References

Boada, Mercè, Oscar L. López, Jesús Olazarán, Lidia Núñez, Martin Pfeffer, Marta Paricio, Jordi Lorites, et al. 2020. “A Randomized, Controlled Clinical Trial of Plasma Exchange with Albumin Replacement for Alzheimer’s Disease: Primary Results of the AMBAR Study.” Alzheimer’s & Dementia 16 (10): 1412–1425. https://doi.org/10.1002/alz.12137

.

“Multi-Omics Analysis Reveals Biomarkers That Contribute to Biological Age Rejuvenation in Response to Therapeutic Plasma Exchange.” n.d. https://doi.org/10.1111/acel.70103

.

Rony, R. M. I. K., A. Shokrani, N. K. Malhi, D. Hussey, R. Mooney, Z. B. Chen, T. Scott, et al. 2025. “Therapeutic Plasma Exchange: Current and Emerging Applications to Mitigate Cellular Signaling in Disease.” Biomolecules 15 (7): 1000. https://doi.org/10.3390/biom15071000

.

Schwartz, J., A. Padmanabhan, N. Aqui, R. A. Balogun, L. Connelly-Smith, M. Delaney, N. M. Dunbar, et al. 2016. “Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.” Journal of Clinical Apheresis 31 (3): 149–162. https://doi.org/10.1002/jca.21470

.

Zhang, X., S. Xu, L. Ye, J. Yin, M. Zhang, Y. Jin, and J. Li. 2026. “Age-Related Changes in Circulating Immune Factors Reveal Biomarkers of Immunosenescence.” Frontiers in Medicine 13: 1729112. https://doi.org/10.3389/fmed.2026.1729112

.

Global Apheresis. n.d. “Therapeutic Plasma Exchange for Detoxification.” https://www.globalapheresis.com/conditions/detoxification